A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 620 participants.

Also called NCT01169090

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 620 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01169090
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01169090. Randomized; double masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2011-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
Intervention (Drug)
SK-0403
Intervention (Drug)
Placebo
Intervention (Drug)
Sitagliptin
Lead sponsor
Kowa Research Institute, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01169090
Content hash
49368dbb9ba6e7fb80a54d831f2f6d6e00e2e1ea88c416c7da45f79f48b28d3a